Camurus AB
Status: Publicly traded
Direct answer
Camurus AB is publicly traded on LSE under the ticker 0RD1.L.
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Can you invest in Camurus AB?
Yes. Camurus AB trades publicly on LSE as 0RD1.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.